Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

XORTX Therapeutics Inc. (C:XRX)

Business Focus: Bio Therapeutic Drugs

Get the company report for the most recent outlook updated daily
Log in or join to add this stock to your watch list.

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for XRX within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Aug 05, 2019 08:35 ET
OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations
Read full article
Aug 05, 2019 08:35 ET
OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing
NEW YORK, Aug. 5, 2019 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the August 1, 2019 OTCQB Venture Company Conference are now available for on-demand viewing at VirtualInvestorConferences.com....
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
--
18.51
12.50
Price to Book - most recent quarter
54.27
3.66
2.69
Price to Cash Flow per share - TTM
--
--
13.28
Price to Free Cash Flow per share - TTM
--
--
16.43
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
May 31, 20192,5000
Mar 31, 201911,7000
Feb 28, 201900
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

XORTX Therapeutics Inc, formerly APAC Resources Inc, is Canada-based biopharmaceutical Company. The Company focuses on developing therapies to treat progressive kidney disease. XORTX Therapeutics Inc has programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. Its development programs focus on potential treatments for Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Diabetic Nephropathy (DN). Its pipeline products: Autosomal Dominant Polycystic Kidney Disease is in Phase II clinical trial, Diabetic Nephropathy is in Phase I clinical trial, and NASH is in the pre-clinical stage.

See business summary

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Twitter

Search (past week) for $XRX.CA

  • No tweets found